Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets
Authors:
- Rasha A. ShaalanRSRasha A. Shaalan
- Tarek S. BelalTBTarek S. Belal
- Fawzy A. El YazbiFYFawzy A. El Yazbi
- Sohila M. ElonsySESohila M. Elonsy
Open Access
- 1 February 2017
- journal article
- Published by Scientific Scholar in Arabian Journal of Chemistry
- Vol. 10, S1381-S1394
Abstract
A simple and selective HPLC-DAD stability indicating method was developed for the simultaneous determination of the three antihypertensive drugs amlodipine besylate (AML), valsartan (VAL) and hydrochlorothiazide (HCT) in their combined formulation. Effective chromatographic separation was achieved using Zorbax SB-C8 column (4.6×250mm, 5μmps) with gradient elution of the mobile phase composed of 0.025M phosphoric acid and acetonitrile at a flow rate of 1mL/min. The multiple wavelength detector was set at 238nm for measurement of AML and 225nm for both VAL and HCT. Quantification was based on measuring the peak areas. The three compounds were resolved with retention times of 4.9, 6.4 and 8.3min for HCT, AML and VAL respectively. Analytical performance of the proposed HPLC procedure was statistically validated with respect to system suitability, linearity, ranges, precision, accuracy, specificity, robustness, detection and quantification limits. The linearity ranges were 5–200, 5–200 and 10–200μg/mL for AML, VAL and HCT respectively with correlation coefficients >0.9993. The three drugs were subjected to stress conditions of acidic and alkaline hydrolysis, oxidation, photolysis and thermal degradation. The proposed method proved to be stability-indicating by resolution of the analytes from their forced-degradation products. The validated HPLC method was applied to the analysis of the cited antihypertensive drugs in their combined pharmaceutical tablets (Exforge HCT). The proposed method made use of DAD as a tool for peak identity and purity confirmationKeywords
This publication has 22 references indexed in Scilit:
- SENSITIVE HPLC METHOD WITH FLUORESCENCE DETECTION AND ON-LINE WAVELENGTH SWITCHING FOR SIMULTANEOUS DETERMINATION OF VALSARTAN AND AMLODIPINE IN HUMAN PLASMAJournal of Liquid Chromatography & Related Technologies, 2011
- DEVELOPMENT AND VALIDATION OF AN HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF AMLODIPINE, HYDROCHLOROTHIAZIDE, AND VALSARTAN IN TABLETS OF THEIR NOVEL TRIPLE COMBINATION AND BINARY PHARMACEUTICAL ASSOCIATIONSJournal of Liquid Chromatography & Related Technologies, 2011
- Single-Pill Triple-Combination Therapy: An Alternative to Multiple-Drug Treatment of HypertensionPostgraduate Medicine, 2011
- Dual separation mode for simultaneous determination of antihypertensive drug combinations by high-performance liquid chromatographyTalanta, 2011
- Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regressionActa Pharmaceutica, 2011
- Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tabletsDrug Testing and Analysis, 2010
- Triple Antihypertensive Therapy With Amlodipine, Valsartan, and HydrochlorothiazideHypertension, 2009
- A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasmaJournal of Chromatography B, 2007
- Spectral Resolution of a Binary Mixture Containing Valsartan and Hydrochlorothiazide in Tablets by Ratio Spectra Derivative and Inverse Least Square TechniquesAnalytical Letters, 2004
- Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LCJournal of Pharmaceutical and Biomedical Analysis, 2001